Latest Commercial Sales News

Page 3 of 9
Mesoblast Limited reported its first commercial sales of FDA-approved Ryoncil, generating $48.7 million in net product sales for the half-year ended December 31, 2025, while reducing its net loss by 16%. The company also secured a $125 million five-year credit facility, restructuring its debt to support ongoing commercialization and development.
Ada Torres
Ada Torres
27 Feb 2026
Neuren Pharmaceuticals reports a 15% rise in 2025 royalties from its partner Acadia’s DAYBUE sales, with strong 2026 guidance signalling further growth. The launch of a new powder formulation and ongoing regulatory efforts in Europe and Japan add to the momentum.
Victor Sage
Victor Sage
26 Feb 2026
XReality Group has reported its strongest half-year performance yet, driven by rapid growth in its Operator XR business focused on immersive training solutions for defence and law enforcement.
Sophie Babbage
Sophie Babbage
26 Feb 2026
xReality Group Limited has reported a robust half-year performance with revenue climbing 41% to $10.4 million, driven by rapid expansion of its Operator XR platform. EBITDA surged 190%, underscoring the company’s successful pivot to software-led immersive training solutions.
Sophie Babbage
Sophie Babbage
26 Feb 2026
Nickel Industries reported a reduced loss after tax of $41.2 million for 2025, underpinned by steady production and strategic progress on its ENC HPAL project and sustainability initiatives.
Maxwell Dee
Maxwell Dee
23 Feb 2026
PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.
Ada Torres
Ada Torres
20 Feb 2026
Li-S Energy narrows its loss to $1.21 million in H1 2026, propelled by a $7.8 million ARENA grant and key manufacturing milestones including Australia’s first lithium metal foil production line. Strategic defence and aerospace partnerships bolster its commercialisation drive.
Maxwell Dee
Maxwell Dee
20 Feb 2026
The US Department of Commerce has finalized hefty antidumping and countervailing duties on Chinese graphite active anode materials, a move expected to strengthen Syrah Resources’ competitive edge in North America and accelerate its US operations.
Maxwell Dee
Maxwell Dee
12 Feb 2026
Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.
Ada Torres
Ada Torres
9 Feb 2026
Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.
Ada Torres
Ada Torres
3 Feb 2026
Wide Open Agriculture has made significant strides in expanding its intellectual property and commercial footprint, including a new patent for lupin protein milk and first sales of lupin oil, while progressing plans for a large-scale manufacturing facility in Western Australia.
Ada Torres
Ada Torres
30 Jan 2026
Sparc Technologies has marked a significant milestone with sustained hydrogen production at its pioneering pilot plant and secured key patents, while also achieving its first commercial sale of graphene additives.
Victor Sage
Victor Sage
30 Jan 2026